The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
Open accessAbstract
BACKGROUND: There are limited data from randomized trials regarding whether volume-based, low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among male former and current smokers. METHODS: A total of 13,195 men (primary analysis) and 2594 women (subgroup analyses) between the ages of 50 and 74 were randomly assigned to undergo CT screening at T0 (baseline), year 1, year 3, and year 5.5 or no screening. We obtained data on cancer diagnosis and the date and cause of death through linkages with national registries in the Netherlands and Belgium, and a review committee confirmed lung cancer as the cause of death when possible. A minimum follow-up of 10 years until December 31, 2015, was completed for all participants. RESULTS: Among men, the average adherence to CT screening was 90.0%. On average, 9.2% of the screened participants underwent at least one additional CT scan (initially indeterminate). The overall referral rate for suspicious nodules was 2.1%. At 10 years of follow-up, the incidence of lung cancer was 5.58 cases per 1000 person-years in the screening group and 4.91 cases per 1000 person-years in the control group; lung-cancer mortality was 2.50 deaths per 1000 person-years and 3.30 deaths per 1000 person-years, respectively. The cumulative rate ratio for death from lung cancer at 10 years was 0.76 (95% confidence interval [CI], 0.61 to 0.94; P = 0.01) in the screening group as compared with the control group, similar to the values at years 8 and 9. Among women, the rate ratio was 0.67 (95% CI, 0.38 to 1.14) at 10 years of follow-up, with values of 0.41 to 0.52 in years 7 through 9. CONCLUSIONS: In this trial involving high-risk persons, lung-cancer mortality was significantly lower among those who underwent volume CT screening than among those who underwent no screening. There were low rates of follow-up procedures for results suggestive of lung cancer. (Funded by the Netherlands Organization of Health Research and Development and others; NELSON Netherlands Trial Register number, NL580.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“demonstrating that low-dose computed tomography substantially reduces deaths from lung cancer.”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,632
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,810
Early Lung Cancer Action Project: overall design and findings from baseline screening
Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G., Miettinen, O. S., Libby, D. M., Pasmantier, M. W., Koizumi, J. H., Altorki, N. K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06093-6 · Cited by 2,504
Mutation and Cancer: A Model for Human Carcinogenesis2
Moolgavkar, S. H., & Knudson, A. G. (1981) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1037 · Cited by 1,078
Mass screening for lung cancer with mobile spiral computed tomography scanner
Sone, S., Takashima, S., Li, F., Yang, Z., Honda, T., Maruyama, Y., Hasegawa, M., Yamanda, T., Kubo, K., Hanamura, K., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08229-9 · Cited by 931
Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography.
Kaneko, M., Eguchi, K., Ohmatsu, H., Kakinuma, R., Naruke, T., Suemasu, K., & Moriyama, N. (1996) · Radiology · doi:10.1148/radiology.201.3.8939234 · Cited by 832
Management of Lung Nodules Detected by Volume CT Scanning
van Klaveren, R. J., Oudkerk, M., Prokop, M., Scholten, E. T., Nackaerts, K., Vernhout, R. M., van Iersel, C. A., van den Bergh, K. A. M., Westeinde, S. C. V. ‘., van der Aalst, C. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906085 · Cited by 817
Self-citationOverdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Patz, E. F., Pinsky, P., Gatsonis, C., Sicks, J. D., Kramer, B. S., Tammemägi, M. C., Chiles, C., Black, W. C., & Aberle, D. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12738 · Cited by 776
Cited by
Sorted by citations
Items 301–400 of 1,001
Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice
Mendoza, D. P., Petranovic, M., Som, A., Wu, M. Y., Park, E. Y., Zhang, E. W., Archer, J. M., McDermott, S., Khandekar, M., Lanuti, M., et al. (2022) · American Journal of Roentgenology · doi:10.2214/ajr.21.27180 · Cited by 44
Adams, S., Mondal, P. K., Penz, E. D., Tyan, C.-C., Lim, H. J., & Babyn, P. (2021) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2020.11.014 · Cited by 43
Sublobar resection is comparable to lobectomy for screen-detected lung cancer
Kamel, M., Lee, B., Harrison, S. W., Port, J. L., Altorki, N. K., & Stiles, B. M. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.06.056 · Cited by 43
Personalized magnetic tentacles for targeted photothermal cancer therapy in peripheral lungs
Pittiglio, G., Chandler, J. H., da Veiga, T., Koszowska, Z., Brockdorff, M., Lloyd, P., Barry, K. L., Harris, R. A., McLaughlan, J. R., Pompili, C., et al. (2023) · Communications Engineering · doi:10.1038/s44172-023-00098-9 · Cited by 43
Khawaja, A. I., Bartholmai, B. J., Rajagopalan, S., Karwoski, R. A., Varghese, C., Maldonado, F., & Peikert, T. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.03.105 · Cited by 43
Tobacco use disorder and the lungs
McRobbie, H. J., & Kwan, B. C. H. (2020) · Addiction · doi:10.1111/add.15309 · Cited by 45
Katsis, J. M., Roller, L. J., Aboudara, M. C., Pannu, J. K., Chen, H., Johnson, J., Lentz, R. J., Rickman, O. B., & Maldonado, F. (2021) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0000000000000766 · Cited by 43
Kalinke, L., Thakrar, R. M., & Janes, S. M. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12864 · Cited by 50
Ou, W., Li, N., Wang, B.-X., Zhu, T., Shen, Z., Wang, T., Chang, W., Chang, Z.-H., Hu, X., Pu, Y., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101839 · Cited by 42
Early-stage ALK-positive lung cancer: a narrative review
Chen, M. F., & Chaft, J. E. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-631 · Cited by 41
The Regimen of Computed Tomography Screening for Lung Cancer
Henschke, C. I., Yip, R., Shaham, D., Zulueta, J. J., Aguayo, S. M., Reeves, A. P., Jirapatnakul, A. C., Avila, R. S., Moghanaki, D. M., & Yankelevitz, D. F. (2020) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000538 · Cited by 45
We need stronger evidence for (or against) hepatocellular carcinoma surveillance
Jepsen, P., & West, J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.12.029 · Cited by 42
Kramer, T., Wijmans, L., de Bruin, D. M., van Leeuwen, T. G. J. M., Radonic, T. R., Bonta, P. I., & Annema, J. T. (2021) · Thorax · doi:10.1136/thoraxjnl-2021-216885 · Cited by 42
Choi, H., Park, Y. S., Na, K. J., Park, S., Park, I. K., Kang, C. H., Kim, Y. T., Goo, J. M., & Yoon, S. H. (2021) · Radiology · doi:10.1148/radiol.2021210576 · Cited by 40
Pan, Z., Zhang, R., Shen, S., Lin, Y., Zhang, L., Wang, X., Ye, Q., Wang, X., Chen, J., Zhao, Y., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104443 · Cited by 44
Expanding the Reach and Grasp of Lung Cancer Screening
Osarogiagbon, R. U., Yang, P., & Sequist, L. V. D. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_389958 · Cited by 41
Diagnostic Yield vs Diagnostic Accuracy for Peripheral Lung Biopsy Evaluation
Leonard, K. M., Low, S., Echanique, C. S., Swanner, B., Johnson, J. E., Dahlberg, G. J., Paez, R., Ratwani, A. P., Shojaee, S., Rickman, O. B., et al. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.12.024 · Cited by 41
Overdiagnosis in lung cancer screening
Callister, M. E. J., Sasieni, P. D., & Robbins, H. A. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30553-1 · Cited by 41
Access to Lung Cancer Screening in the Veterans Health Administration
Boudreau, J., Miller, D. R., Qian, S. X., Núñez, E., Caverly, T. J., & Wiener, R. S. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.02.016 · Cited by 41
Participation in lung cancer screening
Baldwin, D., Brain, K. E., & Quaife, S. L. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-917 · Cited by 40
Lozier, J., Fedewa, S. A., Smith, R. A., & Silvestri, G. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.30350 · Cited by 41
Hewitt, R. J., Bartlett, E., Ganatra, R., Butt, H., Kouranos, V., Chua, F., Kokosi, M. A., Molyneaux, P. L., Desai, S. R., Wells, A. U., et al. (2022) · Thorax · doi:10.1136/thorax-2022-219068 · Cited by 40
Preventive care recommendations to promote health equity
Persaud, N., Sabir, A., Woods, H., Sayani, A., Agarwal, A., Chowdhury, M., de Leon-Demare, K., Ibezi, S., Jan, S. H., Katz, A., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230237 · Cited by 46
Feng, X., Goodley, P., Alcala, K., Guida, F., Kaaks, R., Vermeulen, R. C. H., Downward, G. S., Bonet, C., Colorado-Yohar, S. M., Albanes, D., et al. (2024) · The Lancet Digital Health · doi:10.1016/s2589-7500(24)00123-7 · Cited by 42
Robotic-assisted bronchoscopy: a narrative review of systems
Fernández-Bussy, S., Chandra, N. C., Koratala, A., Lee‐Mateus, A. Y., Barrios‐Ruiz, A., Garza-Salas, A., Koirala, T., Funes‐Ferrada, R., Balasubramanian, P., Patel, N. M., et al. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-456 · Cited by 40
Prognostic Impact of the Histologic Lepidic Component in Pathologic Stage IA Adenocarcinoma
Okubo, Y., Kashima, J., Teishikata, T., Muraoka, Y., Yotsukura, M., Yoshida, Y., Nakagawa, K., Watanabe, H., Kusumoto, M., WATANABE, S.-I. I., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.09.006 · Cited by 40
Zhang, R., Shen, S., Wei, Y., Zhu, Y., Li, Y., Chen, J., Guan, J., Pan, Z., Wang, Y., Zhu, M., et al. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.04.011 · Cited by 44
Almatrafi, A. A., Thomas, O., Callister, M. E. J., Gabe, R., Beeken, R. J., & Neal, R. D. (2022) · Journal of Medical Screening · doi:10.1177/09691413221117685 · Cited by 43
Clinical usefulness of circulating tumor markers
Filella, X., Rodriguez-Garcia, M., & Fernández‐Galán, E. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-1090 · Cited by 39
Tang, L., Yu, H., Dai, W., Yang, X., Wei, X., Wang, X. S., Cleeland, C. S., Li, Q., & Shi, Q. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-022-13065-z · Cited by 41
Wu, Y.-J., Liu, Y.-C., Liao, C.-Y., Tang, E., & Wu, F. (2021) · Scientific Reports · doi:10.1038/s41598-020-79690-4 · Cited by 39
Lung Nodule Malignancy Prediction in Sequential CT Scans: Summary of ISBI 2018 Challenge
Balagurunathan, Y., Beers, A. L., McNitt‐Gray, M. F., Hadjiiski, L. M., Napel, S. A., Goldgof, D. B., Perez, G., Arbeláez, P., Mehrtash, A., Kapur, T., et al. (2021) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2021.3097665 · Cited by 42
Li, J., Wu, J., Zhao, Z., Zhang, Q., Shao, J., Wang, C., Qiu, Z., & Li, W. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-864 · Cited by 43
Low-dose CT for lung cancer screening: position paper from the Italian college of thoracic radiology
Silva, M., Picozzi, G., Sverzellati, N., Anglesio, S., Bartolucci, M., Cavigli, E., Deliperi, A., Falchini, M., Falaschi, F., Ghio, D., et al. (2022) · La radiologia medica · doi:10.1007/s11547-022-01471-y · Cited by 39
Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids
Li, L., Ye, Z., Yang, S., Yang, H., Jin, J., Zhu, Y., Tao, J., Chen, S., Xu, J., Liu, Y., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01163-w · Cited by 39
Liu, Y., Pan, I.-W. E., Tak, H. J., Vlahos, I., Volk, R. J., & Shih, Y. T. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.43163 · Cited by 38
Artificial Intelligence and Machine Learning in Lung Cancer Screening
Adams, S., Mikhael, P. G., Wohlwend, J., Barzilay, R., Sequist, L. V. D., & Fintelmann, F. J. (2023) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2023.03.001 · Cited by 39
Kim, Y. W., Kang, H.-R., Kwon, B. S., Lim, S. Y., Lee, Y. J., Park, J. S., Cho, Y., Yoon, H. I., Lee, K. W., Lee, J. H., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00177-2020 · Cited by 38
Hüsing, A., & Kaaks, R. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00657-w · Cited by 38
Delivering low-dose CT screening for lung cancer: a pragmatic approach
Horst, C., Dickson, J. L., Tisi, S., Ruparel, M., Nair, A., Devaraj, A., & Janes, S. M. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-215131 · Cited by 38
Schotten, L. M., Darwiche, K., Seweryn, M. T., Yildiz, V. O., Kneuertz, P. J., Eberhardt, W., Eisenmann, S., Welter, S., Sisson, B. E., Pietrzak, M., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.032 · Cited by 38
Choi, H., & Mazzone, P. J. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.07.007 · Cited by 38
Lung Cancer Screening in Asbestos-Exposed Populations
Markowitz, S. B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19052688 · Cited by 37
Raoof, S., Shah, M., Make, B. J., Allaqaband, H., Bowler, R. P., Fernando, S. M., Greenberg, H. E., Han, M. K., Hogg, J., Humphries, S. M., et al. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.03.007 · Cited by 37
High risk lung nodule: A multidisciplinary approach to diagnosis and management
Mankidy, B., Mohammad, G., Trinh, K., Ayyappan, A. P., Huang, Q., BUJARSKI, S. R., Jafferji, M. S., Ghanta, R. K., Hanania, A. N., & Lazarus, D. R. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107277 · Cited by 37
Landy, R., Cheung, L. C., Young, C. D., Chaturvedi, A. K., & Katki, H. A. (2023) · Cancer · doi:10.1002/cncr.34758 · Cited by 37
Risk-based lung cancer screening performance in a universal healthcare setting
Tammemägi, M. C., Darling, G. E., Schmidt, H., Walker, M. J., Langer, D. L., Leung, Y. W., Nguyen, K., Miller, B., Llovet, D., Evans, W. K., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02904-z · Cited by 37
Noninvasive biomarkers for lung cancer diagnosis, where do we stand?
Kammer, M. N., & Massion, P. P. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-2019-ndt-10 · Cited by 37
Silva, M., Milanese, G., Sestini, S., Sabia, F., Jacobs, C., van Ginneken, B., Prokop, M., Schaefer‐Prokop, C. M., Marchianò, A. V., Sverzellati, N., et al. (2020) · European Radiology · doi:10.1007/s00330-020-07275-w · Cited by 37
Self-citationAvasarala, S. K., Roller, L. J., Katsis, J. M., Chen, H., Lentz, R. J., Rickman, O. B., & Maldonado, F. (2021) · Respiration · doi:10.1159/000518009 · Cited by 37
Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometry
Tisi, S., Dickson, J. L., Horst, C., Quaife, S. L., Hall, H., Verghese, P., Gyertson, K., Bowyer, V., Levermore, C., Mullin, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00795-2022 · Cited by 36
Cao, W., Tan, F., Liu, K., Wu, Z. L., Wang, F., Yu, Y., Wen, Y., Qin, C., Xu, Y., Zhao, L., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101594 · Cited by 36
Prosper, A. E., Kammer, M. N., Maldonado, F., Aberle, D. R., & Hsu, W. W. Y. (2023) · Radiology · doi:10.1148/radiol.222904 · Cited by 38
Inhalable point-of-care urinary diagnostic platform
Zhong, Q., Tan, E. K. W., Martin-Alonso, C., Parisi, T., Hao, L., Kirkpatrick, J. D., Fadel, T. R., Fleming, H. E., Jacks, T., & Bhatia, S. N. (2024) · Science Advances · doi:10.1126/sciadv.adj9591 · Cited by 35
Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC
Fiste, O., Gkiozos, I., Charpidou, A. G., & Syrigos, N. K. (2024) · Cancers · doi:10.3390/cancers16040831 · Cited by 39
Moussaoui, M., Baammi, S., Soufi, H., Baassi, M., Salah, M., Allali, A. E., Belghiti, M. E., Daoud, R., & Belaaouad, S. (2024) · ACS Omega · doi:10.1021/acsomega.4c04639 · Cited by 36
Cherukuri, S. P., Kaur, A., Goyal, B., Kukunoor, H. R., Sahito, A. F., Sachdeva, P., Yerrapragada, G., Poonguzhali, E., Shariff, M. N., Natarajan, T., et al. (2025) · Cancers · doi:10.3390/cancers17193165 · Cited by 47
Wang, L., Ran, L., Zha, X., Zhao, K., Yang, Y., Shuang, Q., Liu, Y., Hind, K., Cheng, X., & Blake, G. M. (2020) · Archives of Osteoporosis · doi:10.1007/s11657-020-00833-1 · Cited by 36
Nishio, M., Muramatsu, C., Noguchi, S., Nakai, H., Fujimoto, K., Sakamoto, R., & Fujita, H. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104032 · Cited by 35
Gobbini, É., Swalduz, A., Levra, M. G., Ortiz‐Cuaran, S., Toffart, A., Pérol, M., Moro‐Sibilot, D., & Saintigny, P. (2020) · Cancers · doi:10.3390/cancers12113112 · Cited by 36
2020 Innovation-Based Optimism for Lung Cancer Outcomes
Schenk, E. L., Patil, T., Pacheco, J. M., & Bunn, P. A. (2020) · The Oncologist · doi:10.1002/onco.13590 · Cited by 37
Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer
Pérez‐Sánchez, C., Barbarroja, N., Pantaleão, L. C., Lopez-Sanchez, L. M., Ozanne, S. E., Gámez, B. J., Aranda, E., López-Pedrera, C., & Rodríguez‐Ariza, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020111 · Cited by 36
Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma
Chiang, X.-H., Lu, T., Hsieh, M., Tsai, T.-M., Liao, H., Kao, T.-N., Chang, C.-H., Lin, M., Hsu, H., & Chen, J. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10213-9 · Cited by 36
Psychological Targets for Lung Cancer Screening Uptake: A Prospective Longitudinal Cohort Study
Quaife, S. L., Waller, J., Dickson, J. L., Brain, K. E., Kurtidu, C., McCabe, J., Hackshaw, A. K., Duffy, S. W., & Janes, S. M. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.07.025 · Cited by 36
Social Disparities in Lung Cancer Risk and Screening
Raman, V., Yong, V., Erkmen, C. P., & Tong, B. C. (2021) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2021.09.011 · Cited by 36
Broadened Eligibility for Lung Cancer Screening
Henderson, L. M., Rivera, M. P., & Basch, E. (2021) · JAMA · doi:10.1001/jama.2020.26422 · Cited by 36
Novel Image-Guided Flexible-Probe Transbronchial Microwave Ablation for Stage 1 Lung Cancer
Pritchett, M. A., Reisenauer, J. S., Kern, R. M., Wilson, D. S., Meyers, E. E., Szapary, P. O., & Laeseke, P. F. (2023) · Respiration · doi:10.1159/000528820 · Cited by 35
Translating premalignant biology to accelerate non-small-cell lung cancer interception
Mazzilli, S. A., Rahal, Z., Rouhani, M. J., Janes, S. M., Kadara, H. N., Dubinett, S. M., & Spira, A. E. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00791-1 · Cited by 38
Epigenetically inactivated RASSF1A as a tumor biomarker
Raos, D., Ulamec, M., Bojanac, A. K., Bulić‐Jakuš, F., Ježek, D., & Sinčić, N. (2020) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2020.5219 · Cited by 35
Badra, E. V., Baumgartl, M., Fabiano, S., Jongen, A., & Gückenberger, M. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-860 · Cited by 35
The Axonal Glycolytic Pathway Contributes to Sensory Axon Extension and Growth Cone Dynamics
Ketschek, A., Sainath, R., Holland, S. M., & Gallo, G. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0321-21.2021 · Cited by 35
Hu, X., Luo, K., Shi, H. R., Yan, X., Huang, R., Bi, Z., Zhang, J., Xie, D., & Zhang, W. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01233-7 · Cited by 36
Robbins, H. A., Alcala, K., Moez, E. K., Guida, F., Thomas, S., Zahed, H., Warkentin, M. T., Smith‐Byrne, K., Brhane, Y., Muller, D. C., et al. (2022) · Annals of Epidemiology · doi:10.1016/j.annepidem.2022.10.014 · Cited by 35
Zhang, R., Wei, Y., Shi, F., Ren, J., Zhou, Q., Li, W., & Chen, B. (2022) · BMC Cancer · doi:10.1186/s12885-022-10224-z · Cited by 35
Raghu, V. K., Walia, A. S., Zinzuwadia, A. N., Goiffon, R., Shepard, J.-A. O., Aerts, H. J. W. L., Lennes, I. T., & Lu, M. T. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.48793 · Cited by 35
Risk Perception Among a Lung Cancer Screening Population
Turner, J., Pond, G. R., Tremblay, A., Johnston, M. O., Goss, G., Nicholas, G. A., Martel, S., Bhatia, R., Liu, G., Schmidt, H., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.02.050 · Cited by 34
Lee, J. H., Lee, D., Lu, M. T., Raghu, V. K., Park, C. M., Goo, J. M., Choi, S. H., & Kim, H. (2022) · Radiology · doi:10.1148/radiol.212877 · Cited by 34
Accurate classification of lung nodules on CT images using the TransUnet
Wang, H., Zhu, H. H., & Ding, L. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1060798 · Cited by 35
Implementation of Lung Cancer Screening in Primary Care and Pulmonary Clinics
Kukhareva, P., Li, H., Caverly, T. J., Fiol, G. D., Fagerlin, A., Butler, J. M., Hess, R., Zhang, Y., Taft, T., Flynn, M. C., et al. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.04.040 · Cited by 32
Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management
Antunes‐Ferreira, M., D’Ambrosi, S., Arkani, M., Post, E., Veld, S. G. J. G. I. ‘., Ramaker, J., Zwaan, K., Kucukguzel, E. D., Wedekind, L. E., Griffioen, A. W., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35818-w · Cited by 34
Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON Trial
Zhong, D., Sidorenkov, G. A., Jacobs, C., de Jong, P. A., Gietema, H. A., Stadhouders, R., Nackaerts, K., Aerts, J. G. J. V., Prokop, M., Groen, H. J. M., et al. (2024) · Radiology · doi:10.1148/radiol.240535 · Cited by 36
Self-citationNSCLC: Current Evidence on Its Pathogenesis, Integrated Treatment, and Future Perspectives
Tahayneh, K., Idkedek, M., & Akar, F. E. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14031025 · Cited by 37
Walls, G., Oughton, J. B., Chalmers, A. J., Brown, S., Collinson, F. J., Forster, M. D., Franks, K., Gilbert, A., Hanna, G. G., Hannaway, N. L., et al. (2020) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2020.09.006 · Cited by 35
Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors
Lebrett, M. B., Crosbie, E. J., Smith, M. J., Woodward, E. R., Evans, D. G., & Crosbie, P. A. J. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107399 · Cited by 34
Scherübl, H. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1216-7050 · Cited by 34
Shao, J., Wang, G., Yi, L., Wang, C., Lan, T., Xu, X., Guo, J., Deng, T., Liu, D., Chen, B., et al. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2707212 · Cited by 35
Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended
Faselis, C. J., Nations, J. A., Morgan, C. J., Antevil, J. L., Roseman, J. M., Zhang, S., Fonarow, G. C., Sheriff, H. M., Trachiotis, G. D., Allman, R. M., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.2952 · Cited by 34
Greniér, P., Brun, A., & Mellot, F. (2022) · Diagnostics · doi:10.3390/diagnostics12102435 · Cited by 37
Bertolaccini, L., Prisciandaro, E., Bardoni, C., Cara, A., Diotti, C., Girelli, L., & Spaggiari, L. (2022) · Cancers · doi:10.3390/cancers14246157 · Cited by 34
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A. G. N., Celli, B. R., Criner, G. J., Halpin, D. M. G., Anzueto, A., Barnes, P. J., Bourbeau, J., Han, M. K., Martínez, F. J., de, M. M., et al. (2023) · Respirology · doi:10.1111/resp.14486 · Cited by 39
Early Diagnosis and Lung Cancer Screening
Balata, H., Quaife, S. L., Craig, C., Ryan, D., Goodley, P., Crosbie, P. A. J., Murray, R. L., & Evison, M. (2022) · Clinical Oncology · doi:10.1016/j.clon.2022.08.036 · Cited by 35
Diagnostic efficacy of cryobiopsy for peripheral pulmonary lesions: A propensity score analysis
Furuse, H., Matsumoto, Y., Nakai, T., Tanaka, M., Nishimatsu, K., Uchimura, K., Imabayashi, T., Tsuchida, T., & Ohe, Y. (2023) · Lung Cancer · doi:10.1016/j.lungcan.2023.02.022 · Cited by 33
Voss, T., Krag, M., Martiny, F., Heleno, B., Jørgensen, K. J., & Brodersen, J. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102352 · Cited by 33
New trend in artificial intelligence-based assistive technology for thoracic imaging
Yanagawa, M., Ito, R., Nozaki, T., Fujioka, T., Yamada, A., Fujita, S., Kamagata, K., Fushimi, Y., Tsuboyama, T., Matsui, Y., et al. (2023) · La radiologia medica · doi:10.1007/s11547-023-01691-w · Cited by 33
Prevalence and management of pulmonary nodules: a systematic review and meta-analysis
Chen, D., Yang, L., Zhang, W., Shen, J., Schil, P. E. V., Divisi, D., Seetharamu, N., & Gu, J. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-874 · Cited by 33
The Annual Cost of Cancer Screening in the United States
Halpern, M. T., Liu, B., Lowy, D. R., Gupta, S. N., Croswell, J. M., & Doria-Rose, V. P. (2024) · Annals of Internal Medicine · doi:10.7326/m24-0375 · Cited by 33
Lung cancer screening: where do we stand?
Hardavella, G. F., Frille, A., Sreter, K. B., Atrafi, F., Yousaf-Khan, U., Beyaz, F., Kyriakou, F., Bellou, E., Mullin, M. L. L., & Janes, S. M. (2024) · Breathe · doi:10.1183/20734735.0190-2023 · Cited by 34
Self-citationMaldonado, S. G., Motsch, E., Trotter, A., Kauczor, H., Heußel, C. P., Hermann, S., Zeißig, S. R., Delorme, S., & Kaaks, R. (2020) · International Journal of Cancer · doi:10.1002/ijc.33295 · Cited by 33
Triplette, M., Thayer, J. H., Kross, E. K., Cole, A., Wenger, D. S., Farjah, F., Nair, V. S., & Crothers, K. A. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202006-631rl · Cited by 33
Quaife, S. L., Janes, S. M., & Brain, K. E. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1179 · Cited by 33
Metadata
- Authors
- de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., van ’t Westeinde, S., Prokop, M., Mali, W. P., Mohamed Hoesein, F. A. A., van Ooijen, P. M. A., Aerts, J. G. J. V., den Bakker, M. A., Thunnissen, E., Verschakelen, J., Vliegenthart, R., Walter, J. E., ten Haaf, K., Groen, H. J. M., & Oudkerk, M.
- Affiliations
- From the Departments of Public Health (H.J.K., C.M.A., U.Y.-K., K.H.) and Pulmonology (J.G.J.V.A.), Erasmus MC–University Medical Center Rotterdam, and the Departments of Pulmonology (S.W.) and Pathology (M.A.B.), Maasstad Hospital, Rotterdam, the Departments of Radiology (P.A.J., W.P.M., F.A.A.M.H.) and Pulmonology (J.-W.J.L.), University Medical Center Utrecht, Utrecht, the Departments of Radiology (E.T.S.) and Pulmonology (C.W.), Spaarne Gasthuis, Haarlem, the Department of Radiation Oncology,...
- Erasmus MC (NL)
- Leiden University Medical Center (NL)
- University Medical Center Groningen (NL)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-02-06
- Volume
- 382
- Issue
- 6
- Pages
- 503-513
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3003415550
- Cited by
- 3,624
- References
- 76
- Citations by year
- 2026: 538 · 2025: 626 · 2024: 568 · 2023: 588 · 2022: 532 · 2021: 492 · 2020: 275
- FWCI
- 266.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Lirias (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- LOGO Leuven
- The Netherlands Organization of Health Research and Development
- Dutch Cancer Society
- Health Insurance Innovation Foundation
- Siemens Germany
- Roche Diagnostics
- G.Ph. Verhagen Stichting
- Rotterdam Oncologic Study (ROTS) group
- Erasmus Trust Fund
- Stichting Tegen Kanker
- Vlaamse Liga Tegen Kanker
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- lung cancer screening, low-dose CT, lung cancer mortality, smoking, men, women, screening adherence, lung cancer incidence, NELSON trial, cancer mortality reduction, follow-up procedures, cancer registry linkage, Netherlands, vulnerable populations, cost-effectiveness of screening
- MeSH terms
- Medical Overuse, Aged, Belgium, False Positive Reactions, Female, Humans, Lung Neoplasms, Male, Middle Aged, Netherlands, Registries, Sex Factors, Smoking, Incidence, Cone-Beam Computed Tomography, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
